Arthritis & the COVID vaccine: What you need to know
(HealthDay)—Some arthritis drugs may reduce the effectiveness of COVID vaccines, according to the Arthritis Foundation, which also offers advice on booster shots.
Jan 21, 2022
0
25
(HealthDay)—Some arthritis drugs may reduce the effectiveness of COVID vaccines, according to the Arthritis Foundation, which also offers advice on booster shots.
Jan 21, 2022
0
25
Seeing a physician or other health specialist for low back and neck pain? You're not alone, according to a new scientific study.
Mar 3, 2020
0
379
Australian researchers reveal that sudden, acute episodes of low back pain are not linked to weather conditions such as temperature, humidity, air pressure, wind direction and precipitation. Findings published in Arthritis ...
Jul 10, 2014
0
0
Many types of arthritis can affect your musculoskeletal system. Joints are physical points of connection between two bones, and cartilage is the tissue that covers the surface of the bone at the joint. A membrane, called ...
Mar 15, 2023
0
5
Dear Mayo Clinic: Is there a specific test to definitively diagnose fibromyalgia? If not, how do doctors confidently diagnose this disorder?
Jun 13, 2019
0
5
People who develop rheumatoid arthritis as older adults benefit from early and sustained use of a drug called Methotrexate (MTX), a recent study led by University of Toronto researcher Jessica Widdifield has found.
Jul 18, 2019
0
5
(HealthDay)—Oral contraceptives—also known as birth control pills—may ease pain and improve functioning in women with rheumatoid arthritis, a small German study suggests.
Aug 28, 2015
0
61
January is Thyroid Awareness Month, which makes this a good time to learn more about Hashimoto's disease.
Jan 13, 2022
0
8
New research reports a high prevalence of vitamin D insufficiency and deficiency among patients with psoriatic arthritis. Seasonal variation in vitamin D levels was not observed in patients in southern or northern locations. ...
Jul 11, 2011
0
0
(HealthDay)—The U.S. Food and Drug Administration has expanded the approval of Skyrizi (risankizumab-rzaa) to treatment of adults with active psoriatic arthritis, the manufacturer announced Friday.
Jan 26, 2022
0
1